The Pediatric Praziquantel Consortium partners are committed to enhancing awareness, and helping overall global efforts towards...
Read more
Press release
28 March 2014
Pediatric Praziquantel Consortium awarded US$1.86 million GHIT grant
The Pediatric Praziquantel Consortium, launched in 2012 as an international non-profit public-private partnership, has announced that it has been awarded a...
Read more
Press release
25 March 2014
Pediatric Praziquantel Consortium expands into Brazil
Goal is to make treatment for schistosomiasis accessible to children under six years of age in endemic countries.
Read more
Press release
22 August 2013
International partnership receives funding to develop a drug product to fight schistosomiasis (bilharzia) in children
An international public-private partnership (PPP) was launched in July last year to develop a new pediatric formulation to combat schistosomiasis - commonly...
Read more
Press release
02 July 2012
New public-private partnership to develop a treatment for schistosomiasis-infected preschool children
A newly established international public-private partnership (PPP) between TI Pharma, Merck KGaA (Darmstadt, Germany), Astellas Pharma Inc. and the Swiss...
